Shintaro Hirata

Jan 20, 2025 | lupus.bmj.com | Yoshiya Tanaka |Yusuke Miyazaki |Shintaro Hirata |Katsuhide Kusaka

In clinical practice, a lupus low disease activity state (LLDAS) has been proposed as an alternative treatment target for patients with SLE. LLDAS is associated with reduced accrual of organ damage and improvements in quality of life. Patients with SLE in LLDAS experienced a residual disease burden, especially in pain and fatigue, that was associated with activity impairment.